Saturday 17 October 2026
Export DHC’s income statement to Excel — free account
Diversified Healthcare Trust
DHC Real Estate Reit Healthcare Facilities
Diversified Healthcare Trust’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 2.84% from fiscal 2024. In the quarter to June 2026, revenue fell 4.53%, EPS grew 57.9%, free cash flow fell 94.0% and total debt fell 8.86%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three; insiders bought in the last twelve months.
7.59
0.02
−0.26%
Follow DHC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 7 | 3 | 4 | 3 | 1 | 5 | 4 | 5 |
P/E ratio |
31.77 | 31.03 | 9.77 | 0.00 | 0.00 | 4.18 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4.28 | 4.25 | 2.49 | 1.93 | 0.60 | 0.53 | 0.12 | 0.61 | 0.37 | 0.76 |
P/FCF ratio |
34.37 | 23.09 | 5.66 | 8.12 | 8.31 | 0.00 | 0.70 | 0.00 | 0.00 | 2.76 |
P/Operating CF |
55.11 | 53.96 | 26.06 | 28.58 | (2,251.69) | (14.67) | (46.19) | (118.94) | 30.28 | (57.95) |
P/B ratio |
1.41 | 1.39 | 0.88 | 0.70 | 0.37 | 0.28 | 0.06 | 0.37 | 0.28 | 0.70 |
Price to Tangible BV |
1.41 | 1.39 | 0.88 | 0.70 | 0.37 | 0.28 | 0.06 | 0.37 | 0.28 | 0.70 |
EV/Sales |
7.75 | 7.63 | 5.69 | 5.68 | 2.87 | 2.45 | 1.96 | 2.75 | 2.52 | 2.53 |
EV/EBITDA |
13.86 | 14.85 | 12.39 | 15.35 | 18.19 | 13.79 | 16.31 | 20.16 | 14.32 | 28.85 |
EV/Operating CF |
19.32 | 19.54 | 16.19 | 22.23 | 29.58 | (53.61) | (62.37) | 369.87 | 33.52 | (198.51) |
EV/FCF |
62.32 | 41.42 | 12.93 | 23.92 | 39.81 | (18.09) | 11.21 | (18.81) | (68.01) | 9.21 |
Quick Ratio |
1.33 | 0.78 | 1.10 | 1.65 | 1.88 | 1.21 | 0.95 | 8.46 | 4.80 | 2.36 |
Current Ratio |
1.33 | 0.78 | 1.10 | 1.65 | 1.88 | 1.21 | 0.95 | 8.46 | 4.80 | 2.36 |
Net Debt/EBITDA |
6.25 | 6.57 | 7.84 | 10.14 | 14.39 | 10.80 | 15.29 | 13.36 | 10.51 | 16.88 |
Debt/Assets |
51.68% | 50.38% | 57.18% | 59.45% | 58.70% | 55.51% | 50.78% | 51.72% | 56.67% | 55.05% |
Debt/Equity |
1.17 | 1.12 | 1.29 | 1.37 | 1.45 | 1.38 | 1.16 | 1.21 | 1.49 | 1.44 |
Asset Turnover |
0.15 | 0.15 | 0.15 | 0.15 | 0.25 | 0.21 | 0.20 | 0.25 | 0.28 | 0.32 |
Operating CF/Net income |
3.00 | 2.84 | 1.37 | (3.01) | (1.14) | (0.36) | 2.56 | (0.04) | (0.30) | 0.07 |
Capex/Depreciation |
(1.01) | (0.80) | 0.35 | (0.07) | (0.15) | (0.45) | 1.07 | (0.73) | (0.43) | 1.30 |
Interest Coverage |
1.81 | 1.67 | 1.27 | 0.54 | (0.06) | (0.12) | (0.45) | (0.54) | (0.53) | (1.00) |
| 4.31% | 4.56% | 8.89% | (2.91%) | (5.07%) | 6.61% | (0.60%) | (11.80%) | (17.24%) | (15.78%) | |
| 1.96% | 2.03% | 3.97% | (1.28%) | (2.12%) | 2.66% | (0.25%) | (5.13%) | (7.00%) | (6.02%) | |
ROIC |
2.75% | 2.49% | 1.97% | 0.89% | (0.13%) | (0.37%) | (1.17%) | (1.32%) | (1.67%) | (3.25%) |
Return on Tangible Assets |
2.22% | 2.32% | 4.52% | (1.49%) | (2.42%) | 3.32% | (0.33%) | (5.85%) | (8.30%) | (7.27%) |
Average Days of Receivables |
6.36 | 6.30 | 6.11 | 0.70 | 0.00 | 0.00 | 2.48 | 1.57 | 0.99 | 0.94 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
4.40% | 9.65% | 7.69% | 3.56% | 1.87% | 2.46% | 2.06% | 1.85% | 1.77% | 2.96% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.88) | (0.86) | (1.40) | (1.86) | (3.85) | (4.00) | (16.95) | (3.33) | (5.49) | (2.21) |
Graham Number |
13.49 | 13.88 | 19.01 | 0.00 | 0.00 | 13.65 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.15% | 3.22% | 10.24% | (4.38%) | (14.32%) | 23.95% | (9.09%) | (34.26%) | (66.96%) | (24.54%) |
Free Cash Flow Yield |
2.91% | 4.33% | 17.67% | 12.32% | 12.03% | (25.52%) | 142.71% | (24.05%) | (10.04%) | 36.28% |
Revenue per Share |
4.46 | 4.53 | 4.70 | 4.38 | 6.86 | 5.81 | 5.39 | 5.90 | 6.24 | 6.40 |
Operating CF per Share |
1.79 | 1.77 | 1.65 | 1.12 | 0.67 | (0.27) | (0.17) | 0.04 | 0.47 | (0.08) |
Capex per Share |
(1.23) | (0.93) | 0.42 | (0.08) | (0.17) | (0.52) | 1.11 | (0.91) | (0.70) | 1.84 |
Free Cash Flow per Share |
0.55 | 0.83 | 2.07 | 1.04 | 0.50 | (0.79) | 0.94 | (0.86) | (0.23) | 1.76 |
Cash per Share |
0.15 | 0.20 | 0.30 | 0.22 | 0.38 | 4.27 | 2.89 | 1.03 | 0.63 | 0.51 |
Shareholders Equity per Share |
13.48 | 13.80 | 13.39 | 12.11 | 11.02 | 11.19 | 11.07 | 9.78 | 8.18 | 6.93 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.48 | 13.80 | 13.39 | 12.11 | 11.02 | 11.19 | 11.07 | 9.78 | 8.18 | 6.93 |
Free Cash Flow |
131.61 | 197.87 | 491.93 | 247.03 | 117.82 | (187.67) | 224.47 | (206.17) | (55.31) | 422.79 |
Working Capital |
13.25 | (18.54) | 8.29 | 21.38 | 42.53 | 178.83 | (37.60) | 223.13 | 121.83 | 72.39 |
Capital Expenditures |
(292.87) | (221.43) | 99.09 | (18.81) | (40.72) | (124.35) | 264.82 | (216.65) | (167.53) | 442.41 |
Net Current Asset Value |
(3,974.33) | (3,950.97) | (3,891.78) | (3,722.56) | (3,766.35) | (2,944.18) | (2,666.46) | (2,856.20) | (3,024.25) | (2,569.91) |
EV/EBIT |
27.06 | 29.78 | 28.04 | 61.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.28 | 0.21 | (0.09) | 0.02 | 0.03 | 0.09 | (0.21) | 0.15 | 0.11 | (0.29) |
Price to Operating Income |
14.93 | 16.60 | 12.27 | 20.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.09 | 0.09 |
Cash ROIC |
1.89% | 2.83% | 6.70% | 3.59% | 1.81% | (2.55%) | 3.52% | (3.82%) | (1.10%) | 10.09% |
Accounts Receivable Turnover |
58.21 | 58.13 | 60.00 | 100.54 | 0.00 | 0.00 | 239.78 | 190.62 | 295.01 | 383.03 |
Accounts Payable Turnover |
21.43 | 9.32 | 7.48 | 15.51 | 74.20 | 66.54 | 164.65 | 191.49 | 154.09 | 79.48 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
20.36 | 58.62 | 43.89 | 6.55 | 7.25 | 2.76 | 1.71 | 2.20 | 2.65 | 6.58 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
18.18 | 18.49 | 18.62 | 10.35 | — | — | 5.35 | 7.40 | 5.07 | 4.02 |
Average Payables |
18.65 | 44.35 | 60.36 | 31.54 | 16.66 | 16.41 | 6.74 | 6.13 | 8.03 | 15.84 |
Average Assets |
7,193.92 | 7,260.89 | 7,227.22 | 6,907.13 | 6,565.13 | 6,549.97 | 6,312.80 | 5,724.11 | 5,291.57 | 4,749.13 |
Average Common Equity |
3,279.58 | 3,238.30 | 3,228.53 | 3,028.46 | 2,748.14 | 2,640.81 | 2,650.50 | 2,487.75 | 2,147.87 | 1,812.21 |
Columns are period end dates